Explore our certified CRO/CDMO services structured to streamline product development protocols for pharmaceutical, nutraceutical, and clinical institutions worldwide.
The transition toward verifiable, evidence-based botanical manufacturing is revolutionizing global markets, establishing stringent analytical criteria over traditional anecdotal claims.
Botanical matrices suffer from substantial variance caused by geographic latitude, microclimates, harvesting seasons, and regional soil chemistry. Standardizing batch-to-batch content demands advanced chromatographic finger-printing, multi-origin comparative assays, and rigid baseline normalization to fulfill strict Western pharmacopeial limits.
Global regulatory bodies including the US FDA (21 CFR Part 111/312), EMA, and NMPA strictly enforce safety profiles. Natural extracts must pass definitive toxicity profiling—encompassing acute LD50 determinations, repeated-dose subchronic studies, bacterial reverse mutation assays, and genotoxic assays—to confirm safety prior to clinical trials.
Transitioning from benchtop extraction in a research environment to commercial multi-ton cGMP production often results in severe active yield losses, thermal decomposition, and precipitation bottlenecks. Integrated CDMOs bridge this gap with real-time pilot plant scale-ups and continuous crystallization technologies.
Combining classical ethnobotanical wisdom with modern biochemical assays to engineer scalable, clinically sound formulations that accelerate time-to-market.
Applying high-throughput biophysical assays and mass spectrometry metabolomics to identify specific alkaloids, polyphenols, saponins, and polysaccharides. We correlate precise bioactive structures with targeted therapeutic pathways to eliminate non-active ballast fractions early.
Formulating rigorous quantitative and qualitative protocols via HPTLC, reversed-phase HPLC-DAD/MS, and GC-FID/MS. We supply full system suitability documentation, chromatographic fingerprinting, reference standards, and ICH-compliant stability testing packages.
Delivering GLP-compliant in vitro cellular models and in vivo rodent animal studies to validate pharmacodynamics, systemic absorption, and targeted organ toxicity. Our reports serve as robust dossiers for Institutional Review Board (IRB) and IND filings.
Collaborating with tier-one clinical trial centers and university-affiliated hospitals to execute randomized, double-blind, placebo-controlled clinical protocols. We manage patient cohort recruitment, statistical endpoints, GCP documentation, and publication-ready datasets.
Translating historical Classical Traditional Chinese Medicine formulas into standardized pharmaceutical intermediates. Over 83 classic prescriptions modernized with established bio-equivalence, refined flavor profiling, and verified bioavailability profiles.
cGMP-compliant pilot-to-commercial manufacturing capacities for both intermediate botanical APIs and final dosage forms. We deliver oral liquids, hard/softgel capsules, effervescent tablets, micro-granules, and liposomal delivery systems.
Ensuring overseas enterprises launch products compliant with both domestic market access mandates and target Western regulatory criteria.
All research and contract manufacturing are conducted strictly under bilateral Non-Disclosure Agreements (NDAs). Proprietary synthetic biological modifications, extraction pathways, and blending ratios remain the exclusive intellectual property of the commissioning partner.
Our labs operate under unified standards aligning with the United States Pharmacopeia (USP), European Pharmacopoeia (Ph. Eur.), and Chinese Pharmacopoeia (ChP). We assure heavy metals, pesticide residues, and mycotoxins consistently clear ICP-MS and GC-MS/MS testing.
Direct assistance in preparing Drug Master Files (DMF), New Dietary Ingredient (NDI) notifications, and Generally Recognized as Safe (GRAS) self-affirmations. We fast-track hospital preparation registrations (56+ successfully filed to date).
Real-world delivery systems optimized across multiple high-growth segments in global commerce.
Custom hospital preparation formulations developed for internal hospital networks. We conduct batch consistency assays, optimize oral bio-absorption, and formalize standard operating guidelines matching clinical protocols.
High-solubility, deodorized, and microencapsulated extracts suitable for gummies, ready-to-drink beverages, and stick-pack sachets with high stability against oxidation, temperature fluctuation, and pH changes.
Botanical fractions engineered for transdermal penetration targeting anti-aging, barrier repair, anti-inflammatory modulation, and tyrosinase inhibition, supported by cellular cytokine assays.
A multi-year methodology integrating modern bioinformatics and green extraction processing into next-generation natural product development.
Utilizing proprietary phytochemical relational databases to predict binding affinities between complex herbal molecules and human disease receptors, compressing exploratory screening timelines by over 60%.
Deploying supercritical CO2 extraction and ultrasonic counter-current continuous separation arrays to achieve clean extracts without toxic organic residues, preserving thermolabile structures.
Engineering solid self-nanoemulsifying drug delivery systems (SNEDDS), liposomal complexes, and cyclodextrin inclusions to maximize the intestinal absorption rate of low-solubility botanical compounds.
Integrating in-line NIR spectroscopy and automated feedback adjustments into industrial extraction loops to achieve verifiable real-time monitoring and consistent commercial batch outputs.
Detailed insights on engaging our specialized natural medicine CRO and CDMO product development platform.
Review our core contract formulations, extraction programs, and preclinical study options engineered for rapid international supply and verified regulatory conformity.
